Gastroenterology Clinic Follow-Up Reduces Gastroenterology-Specific Readmissions Among Patients With Severe Ulcerative Colitis

被引:2
作者
Barber, Grant E. [1 ]
Zhuo, Justin [2 ]
Okafor, Philip N. [3 ]
Streett, Sarah [1 ]
机构
[1] Stanford Univ, Dept Gastroenterol & Hepatol, Redwood City, CA USA
[2] Rutgers State Univ, Dept Gastroenterol & Hepatol, Newark, NJ USA
[3] Mayo Clin, Dept Gastroenterol & Hepatol, Jacksonville, FL 32224 USA
关键词
IBD; epidemiology; quality; admission; INFLAMMATORY-BOWEL-DISEASE; MANAGEMENT; THERAPY; CARE; RISK;
D O I
10.1093/ibd/izad207
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and aims: Readmission within 30 days occurs in up to 18% of admitted patients with ulcerative colitis (UC). The importance of postdischarge follow-up with a gastroenterologist as well as the optimal follow-up interval is unknown.Methods: We conducted a retrospective cohort study of patients with UC who were admitted to Stanford University Hospital between 2010 and 2020. We included adult patients with UC who were admitted for a UC flare. Patients with a colectomy during hospitalization or with Clostridium difficile infection at the index hospitalization were excluded. The primary outcome was time to readmission for a gastroenterology (GI) indication, and the primary predictor (time dependent) was follow-up with a GI provider. Patients were followed for 180 days after discharge. Data were analyzed using a Cox proportional hazards model.Results: Of the 223 patients hospitalized with UC during the study period, 25% (n = 57) were readmitted within 180 days, with 13.9% occurring within 30 days. Early follow-up (within 7 days) was observed in 29% (n = 65) of patients, while 30-day follow-up was seen in 68.7% (n = 153), and follow-up within 180 days was seen in 198 (89%) patients. In the adjusted Cox proportional hazards model, GI follow-up was associated with fewer readmissions (hazard ratio, 0.42; 95% confidence interval, 0.22-0.81; P = .009). Early follow-up was strongly associated with a reduced risk of readmission (hazard ratio, 0.24; 95% 95% confidence interval, 0.09-0.69; P = .008). Follow-up in 7 days was associated with fewer readmissions (P < .0001).Conclusions: Outpatient GI follow-up after UC hospitalization reduces readmissions, with the greatest reduction occurring among patients followed up within 1 week of discharge.
引用
收藏
页码:1319 / 1325
页数:7
相关论文
共 20 条
[1]   Toxic megacolon [J].
Autenrieth, Daniel M. ;
Baumgart, Daniel C. .
INFLAMMATORY BOWEL DISEASES, 2012, 18 (03) :584-591
[2]   Nutritional Aspects in Inflammatory Bowel Diseases [J].
Balestrieri, Paola ;
Ribolsi, Mentore ;
Guarino, Michele Pier Luca ;
Emerenziani, Sara ;
Altomare, Annamaria ;
Cicala, Michele .
NUTRIENTS, 2020, 12 (02)
[3]   Rising Incidence of Intestinal Infections in Inflammatory Bowel Disease: A Nationwide Analysis [J].
Barber, Grant E. ;
Hendler, Steven ;
Okafor, Philip ;
Limsui, David ;
Limketkai, Berkeley N. .
INFLAMMATORY BOWEL DISEASES, 2018, 24 (08) :1849-1856
[4]  
Dahiya Dushyant Singh, 2022, World J Gastrointest Pathophysiol, V13, P85, DOI [10.4291/wjgp.v13.i3.85, 10.4291/wjgp.v13.i3.85]
[5]  
Feuerstein C., 2014, GASTROENTEROLOGY, V146, pS
[6]   Glucocorticosteroid Therapy in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis [J].
Ford, Alexander C. ;
Bernstein, Charles N. ;
Khan, Khurram J. ;
Abreu, Maria T. ;
Marshall, John K. ;
Talley, Nicholas J. ;
Moayyedi, Paul .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 (04) :590-599
[7]   Optimal Management of Acute Severe Ulcerative Colitis (ASUC): Challenges and Solutions [J].
Holvoet, Tom ;
Lobaton, Triana ;
Hindryckx, Pieter .
CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, 2021, 14 :71-81
[8]   Infliximab as rescue therapy in severe to moderately severe ulcerative colitis:: A randomized, placebo-controlled study [J].
Järnerot, G ;
Hertervig, E ;
Friis-Liby, I ;
Blomquist, L ;
Karlé, P ;
Grännö, C ;
Vilien, M ;
Ström, M ;
Danielsson, Å ;
Verbaan, H ;
Hellström, PM ;
Magnuson, A ;
Curman, B .
GASTROENTEROLOGY, 2005, 128 (07) :1805-1811
[9]   Ulcerative Colitis: Current and Emerging Treatment Strategies [J].
Kayal, Maia ;
Shah, Shailja .
JOURNAL OF CLINICAL MEDICINE, 2020, 9 (01)
[10]  
Kruger Andrew J, 2019, Inflamm Bowel Dis, V25, P894, DOI 10.1093/ibd/izy297